Astrana Health (ASTH) Current Deferred Revenue (2023 - 2025)

Astrana Health's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $2.7 million for Q4 2025.

• In Q4 2025, Current Deferred Revenue rose 65.57% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $2.7 million (up 65.57% YoY), while the FY2025 annual figure was $2.7 million, up 65.57% from the prior year.
• Current Deferred Revenue came in at $2.7 million for Q4 2025 at Astrana Health, up from $686000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $2.7 million in Q4 2025 to a low of $686000.0 in Q1 2025.
• A 3-year average of $1.8 million and a median of $1.9 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue soared 115.86% in 2024 and surged 65.57% in 2025, its largest moves.
• Astrana Health's Current Deferred Revenue stood at $744000.0 in 2023, then jumped by 115.86% to $1.6 million in 2024, then soared by 65.57% to $2.7 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.7 million, $686000.0, and $1.6 million for Q4 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison